Breast cancer survivors' opinion on personalizing endocrine therapy and developing informative tools.

ABSTRACT: Understanding breast cancer survivors' perspectives is critical to personalizing endocrine therapy (ET) in the adjuvant setting. A nationwide survey among breast cancer survivors was proposed in France, in collaboration with patient advocacy organizations, to assess their perspectives on personalizing ET and developing dedicated informative tools. This survey explored patients' preferences regarding ET intake schedule, formulation, presentation (color, taste, shape, size, design, and packaging), combination with agents targeting ET-related adverse events, and a mobile application to support them during ET. Of the 1103 individuals who started the survey, 939 (85.1%) were eligible for enrollment and completed the survey. The majority of the participants considered that a personalized ET shou

SUBMITTER: Rassy E 

PROVIDER: S-EPMC11183231 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature